**Core Concept**
The patient's worsening blood pressure control despite adherence to medications is likely related to the physiological changes associated with chronic kidney disease (CKD) and its treatment, specifically hemodialysis. The body's response to reduced erythropoietin production and fluid overload during hemodialysis can lead to hypertension.

**Why the Correct Answer is Right**
During hemodialysis, the removal of excess fluid and electrolytes can lead to a rebound effect, causing a release of catecholamines and activation of the renin-angiotensin-aldosterone system (RAAS). This results in vasoconstriction and fluid retention, contributing to increased blood pressure. Additionally, the reduction in erythropoietin levels can lead to anemia, further exacerbating hypertension due to increased erythropoietin resistance and subsequent activation of the RAAS.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not directly related to the physiological changes associated with hemodialysis and CKD.
* **Option B:** Although fluid overload is a common issue in CKD patients, it is not the most likely cause of worsening blood pressure control in this scenario, as the patient is on hemodialysis.
* **Option D:** This option is not a direct consequence of hemodialysis and CKD.

**Clinical Pearl / High-Yield Fact**
In patients on hemodialysis, it is essential to monitor blood pressure closely, as the rebound effect can lead to severe hypertension. This is often referred to as "post-dialysis rebound hypertension."

**Correct Answer:** B.